Adidas Rx Series vs Lok Carb-on Hype Gen 2 2026 FDB
Head-to-head on PRR scores, specs, and live prices — independently tested with the same methodology. Updated daily.
Lok Carb-on Hype Gen 2 2026 FDB wins by 10 points
Lok Carb-on Hype Gen 2 2026 FDB scores 82/100 against 72/100 for the Adidas Rx Series. Its biggest edge is power (+21). The Adidas Rx Series answers back on sweet spot (+14). On price, the Adidas Rx Series is currently €94 cheaper.
“The Rx Series 2026 is adidas's recovery-and-rehabilitation frame in all but name: head-light, with an EVA Performance core and fibreglass face scoring comfort 76, tolerance 78 and maneuverability 78, with control 75 keeping placement dependable. Power 64 states the gentle brief. Weight documentation is incomplete. Value 76 is fair. The Rx name lands closer to honest than most: this is equipment for arms under management, players returning from injury, and anyone prescribing themselves kindness. Within that clinic, one of the more complete options at sensible money.”
“The Lok Carb-on Hype Gen 2 comes from a brand with very limited market presence and virtually no established reputation in the competitive padel ecosystem, making it difficult to verify performance claims like 'FDB' technology or the 2026 model year designation. What little is known suggests a mid-diamond shape with carbon layering that prioritizes power over finesse, but the execution feels inconsistent and the spec transparency is poor for the price point. Intermediate players seeking a power-oriented diamond racket would be better served by established brands like Bullpadel, Head, or NOX at similar or lower price points.”
Want a different head-to-head? Compare any rackets in our database side by side.
Open compare tool
